524636 OXYGENTAPH

Oxygenta Pharmaceutical Share Price

 

 

Start SIP in OXYGENTAPH

Start SIP

Performance

  • Low
  • ₹59
  • High
  • ₹61
  • 52 Week Low
  • ₹51
  • 52 Week High
  • ₹134
  • Open Price₹60
  • Previous Close₹59
  • Volume7,532
  • 50 DMA₹58.77
  • 100 DMA₹63.41
  • 200 DMA₹69.68

Investment Returns

  • Over 1 Month + 8.87%
  • Over 3 Month -9.18%
  • Over 6 Month -40.26%
  • Over 1 Year -35.65%

Smart Investing Starts Here Start SIP with Oxygenta Pharmaceutical for Steady Growth!

Invest Now

Oxygenta Pharmaceutical Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -12
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 217
  • P/B Ratio
  • -5.9
  • Average True Range
  • 3.51
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.74
  • RSI
  • 50.96
  • MFI
  • 64.37

Oxygenta Pharmaceutical Financials

Oxygenta Pharmaceutical Technicals

EMA & SMA

Current Price
₹58.55
+ 0.05 (0.09%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹58.46
  • 50 Day
  • ₹58.77
  • 100 Day
  • ₹63.41
  • 200 Day
  • ₹69.68

Resistance and Support

59.28 Pivot Speed
  • R3 62.30
  • R2 61.53
  • R1 60.05
  • S1 57.80
  • S2 57.03
  • S3 55.55

Oxygenta Pharmaceutical Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-04 Quarterly Results
2025-11-07 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results
2025-02-14 Quarterly Results

Oxygenta Pharmaceutical F&O

Oxygenta Pharmaceutical Shareholding Pattern

55.93%
0.03%
38.91%
5.13%

Oxygenta Pharmaceutical FAQs

Oxygenta Pharmaceutical share price is ₹58 As on 10 February, 2026 | 07:33

The Market Cap of Oxygenta Pharmaceutical is ₹216.5 Cr As on 10 February, 2026 | 07:33

The P/E ratio of Oxygenta Pharmaceutical is -12 As on 10 February, 2026 | 07:33

The PB ratio of Oxygenta Pharmaceutical is -5.9 As on 10 February, 2026 | 07:33

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23